Biological and Pharmaceutical Bulletin · 2009 · 78 citations · 20 references
Life SciencesBiochemistryBiocatalysisEnzymologyNatural Product BiosynthesisGlycan DegradationGlycosidic Bond HydrolysisCatalytic EfficiencyCatalytic SpecificityGlycosidase PathwaysGlycosidasesHigh-performance Liquid ChromatographyLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisThermostable Glycosidases
The rare ginsenosides compound K, compound Y, and compound Mc were produced from the major ginsenosides Rb(1), Rb(2), Rc, and Rd by a thermostable beta-glycosidase from Sulfolobus acidocaldarius via three pathways: Rb(1)-->Rd-->compound K, Rb(2)-->compound Y-->compound K, and Rc-->compound Mc. Each of the ginsenosides was identified by high-performance liquid chromatography using standards and liquid chromatography-mass spectrometry based on their molecular weights. The catalytic efficiency of the enzyme for ginsenosides followed the order Rb(1) (4.8)>Rc (4.5)>Rd (1.0)>Rb(2) (0.77 mM(-1) min(-1)). The enzyme converted 1 mg/ml reagent-grade Rb(1), Rb(2), and Rc to 0.53 mg/ml compound K, 0.56 mg/ml compound Y, and 0.70 mg/ml compound Mc, respectively, at pH 5.5 and 85 degrees C after 180 min, corresponding to mole conversion yields of 94, 80, and 100% (mol/mol), respectively. The enzyme converted the major ginsenosides Rb(1), Rb(2), Rc, and Rd in 10% (w/v) ginseng root extract to the rare ginsenosides with a mole yield of 99% after 24 h. These results suggest that beta-glycosidase from S. acidocaldarius can be used to produce compound K, compound Y, and compound Mc.
20
Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.
Minchenko Oh, Y H Choi, Sooseok Choi et al. · International Journal of Oncology · 1999 · 155 citations
Medicine, Oncology, Pharmacology +14